T0	Interventions 674 769	15-day study periods during which 250 mg theophylline twice daily or matching placebo was used.
T1	Interventions 770 973	On the final day of each period, hyperinsulinemic (360 pmol x m(-2) x min(-1)) hypoglycemic (5.0, 3.5, 2.5 mmol x L(-1)) glucose clamps were used to assess counterregulatory and cardiovascular responses.